EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update

Silvia Sookoian, Yaron Rotman, Luca Valenti

Clinical Gastroenterology and Hepatology · 2024-11 · 22 (11) · 2177-2187.e3

DOI: 10.1016/j.cgh.2024.05.052 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Gastroenterology and Hepatology, 2024-11. Verfasst von Silvia Sookoian und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Molecular Hepatology, Translational Health Research Center (CENITRES), Maimónides University, Buenos Aires, Argentina; Faculty of Health…. Hauptthemen laut MEDLINE: Genetic Predisposition to Disease. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, Horizon 2020, European Horizon.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recent advances in the genetics of metabolic dysfunction-associated steatotic liver disease (MASLD) are gradually revealing the mechanisms underlying the heterogeneity of the disease and have shown promising results in patient stratification. Genetic characterization of the disease has been rapidly developed using genome-wide association studies, exome-wide association studies, phenome-wide association studies, and whole exome sequencing. These advances have been powered by the increase in computational power, the development of new analytical algorithms, including some based on artificial intelligence, and the recruitment of large and well-phenotyped cohorts. This review presents an update on genetic studies that emphasize new biological insights from next-generation sequencing approaches. Additionally, we discuss innovative methods for discovering new genetic loci for MASLD, including rare variants. To comprehensively manage MASLD, it is important to stratify risks. Therefore, we present an update on phenome-wide association study associations, including extreme phenotypes. Additionally, we discuss whether polygenic risk scores and targeted sequencing are ready for clinical use. With particular focus on precision medicine, we introduce concepts such as the interplay between genetics and the environment in modulating genetic risk with lifestyle or standard therapies. A special chapter is dedicated to gene-based therapeutics. The limitations of approved pharmacological approaches are discussed, and the potential of gene-related mechanisms in therapeutic development is reviewed, including the decision to perform genetic testing in patients with MASLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic Predisposition to DiseaseHumansFatty LiverGenome-Wide Association StudyHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

GWASGeneticsHSD17B13MASLDNAFLDPNPLA3TM6SF2

Autor:innen und Institutionen

  • Clinical and Molecular Hepatology, Translational Health Research Center (CENITRES), Maimónides University, Buenos Aires, Argentina; Faculty of Health Science, Maimónides University, Buenos Aires, Argentina; Consejo Naci…
  • Liver & Energy Metabolism Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland.
  • Precision Medicine - Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Mila…

Förderung

  • Intramural NIH HHS
  • Horizon 2020
  • European Horizon
  • Agencia Nacional De Promoción Científica Y Tecnológica

Zitieren

APA

Sookoian, S., Rotman, Y., & Valenti, L. (2024). Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update. Clinical Gastroenterology and Hepatology, 22(11), 2177-2187.e3. https://doi.org/10.1016/j.cgh.2024.05.052

Vancouver

Sookoian S, Rotman Y, Valenti L. Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update. Clinical Gastroenterology and Hepatology. 2024;22(11):2177-2187.e3. doi:10.1016/j.cgh.2024.05.052

BibTeX
@article{Sookoian2024,
  author = {Sookoian, Silvia and Rotman, Yaron and Valenti, Luca},
  title = {Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease: The State of the Art Update},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2024},
  volume = {22},
  number = {11},
  pages = {2177--2187.e3},
  doi = {10.1016/j.cgh.2024.05.052}
}
Kostenlos starten →